Mar 29, 2019   SOURCE: PR NewsWire

Global Spasticity Treatment Market 2019-2023 - Key Vendors are Allergan, F. Hoffmann-La Roche, Ipsen Pharma, Pfizer & UCB S.A.

DUBLIN, March 29, 2019 /PRNewswire/ -- The "Global Spasticity Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The spasticity treatment market will register a CAGR of close to 4% by 2023.

The growing popularity of physical therapy is one of the key factors driving the growth of global spasticity treatment market. Patients are increasingly adopting this physical therapy treatment because it has minimal side effects. Several advantages of physiotherapy are encouraging various hospitals to invest in a physiotherapy center. Similarly, many healthcare authorities and hospitals of several countries are working on opening physical therapy centers in hospitals for the treatment of many chronic conditions such as spasticity. This will lead to increase patient adherence and is expected to drive the growth of the global spasticity treatment market during the forecast period.

Market Overview

Availability of advanced technologies for drug delivery

One of the growth drivers of the global spasticity treatment market is the availability of advanced technologies for drug delivery. The growing novel drug delivery systems help in delivering the drugs to the target site for improving treatment efficacy, which will drive the market growth during the forecast period.

A long time is taken to gain benefits in physical therapy

One of the challenges in the growth of the global spasticity treatment market is the long time taken to gain benefits in physical therapy. Several limitations such as long duration of physical therapy coupled with its high treatment costs and differences in service delivery create a negative impact on the growth of the market during the forecast period.

Competitive Landscape

The market appears to be moderately fragmented and with the presence of several vendors. The vendors in the market are focusing on developing neurostimulation devices to treat spasticity in combination with medications available because sometimes physical therapies are compounded by the adverse side-effects.

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

    --  Market ecosystem
    --  Market characteristics
    --  Market segmentation analysis

PART 04: MARKET SIZING

    --  Market definition
    --  Market sizing 2018
    --  Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

    --  Bargaining power of buyers
    --  Bargaining power of suppliers
    --  Threat of new entrants
    --  Threat of substitutes
    --  Threat of rivalry
    --  Market condition

PART 06: MARKET SEGMENTATION BY TYPE

    --  Market segmentation by type
    --  Comparison by type
    --  Drug therapy - Market size and forecast 2018-2023
    --  Physical therapy - Market size and forecast 2018-2023
    --  Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

    --  Geographic segmentation
    --  Geographic comparison
    --  North America - Market size and forecast 2018-2023
    --  Europe - Market size and forecast 2018-2023
    --  Asia - Market size and forecast 2018-2023
    --  ROW - Market size and forecast 2018-2023
    --  Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

    --  Market drivers
    --  Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

    --  Overview
    --  Landscape disruption
    --  Competitive scenario

PART 13: VENDOR ANALYSIS

    --  Vendors covered
    --  Vendor classification
    --  Market positioning of vendors
    --  Allergan
    --  F. Hoffmann-La Roche Ltd
    --  Ipsen Pharma
    --  Pfizer Inc.
    --  UCB S.A.

PART 14: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/m66mfx/global_spasticity?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-spasticity-treatment-market-2019-2023---key-vendors-are-allergan-f-hoffmann-la-roche-ipsen-pharma-pfizer--ucb-sa-300820319.html

SOURCE Research and Markets